[Bicarbonate hemodialysis in the therapy of chronic kidney failure]

Ter Arkh. 1988;60(5):76-80.
[Article in Russian]

Abstract

A method of random sampling was applied to 10 CRI patients to analyze the results of 24 hemodialyses with acetate solution for dialysis (35 mmol/l) and 34 hemodialyses with bicarbonate solution for dialysis (35 mmol/l). Significant reduction of complications like headache, nausea, vomiting, tachycardia, dyspnea, extrasystole was observed in bicarbonate dialysis. The concentration of mean molecular uremic toxins was decreased from 5.75 +/- 0.84 mmol/l in acetate dialysis up to 2.63 +/- 0.21 mmol/l in bicarbonate dialysis. The content of intracellular potassium returned to normal. The concentration of serum cholesterol was decreased from 5.6 +/- 0.4 up to 4.8 +/- 0.2 mmol/l. These data indicated a favorable effect of bicarbonate dialysis on intracellular metabolism. Preliminary data did not confirm the normalizing effect of bicarbonate dialysis on the development of uremic osteopathy.

Publication types

  • Comparative Study
  • English Abstract

MeSH terms

  • Acetates / adverse effects
  • Acetates / therapeutic use
  • Adolescent
  • Adult
  • Bicarbonates / adverse effects
  • Bicarbonates / therapeutic use*
  • Dialysis Solutions / therapeutic use*
  • Evaluation Studies as Topic
  • Female
  • Hemodialysis Solutions / adverse effects
  • Hemodialysis Solutions / therapeutic use*
  • Humans
  • Kidney Failure, Chronic / blood
  • Kidney Failure, Chronic / complications
  • Kidney Failure, Chronic / therapy*
  • Male
  • Middle Aged
  • Renal Dialysis / methods*

Substances

  • Acetates
  • Bicarbonates
  • Dialysis Solutions
  • Hemodialysis Solutions